Liam A. Ridge

Liam A. Ridge

Auto-generated profile, based on publicly available information

Liam A. Ridge

School of Biological and Chemical Sciences, Manchester Metropolitan University, Manchester, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SCSimon John Clark
Simon John Clark
LRLiam A Ridge
Liam A Ridge
AHAndrew P. Herbert
Andrew P. Herbert
SHSvetlana Hakobyan
Svetlana Hakobyan
BMBarbara Mulloy
Barbara Mulloy
ADAnthony Day
Anthony Day
Complement factor H (CFH) regulates complement activation in host tissues through its recognition of polyanions, which mediate CFH binding to host cell surfaces and extracellular matrix, promoting the deactivation of deposited C3b. These polyanions include heparan sulfate (HS), a glycosaminoglycan with a highly diverse range of structures, for which two regions of CFH (CCP6–8 and CCP19–20) have been implicated in HS binding. Mutations/polymorphisms within these glycosaminoglycan-binding sites have been associated with age-related macular degeneration (AMD) and atypical hemolytic uremic syndrome. In this study, we demonstrate that CFH has tissue-specific binding properties mediated through its two HS-binding regions. Our data show that the CCP6–8 region of CFH binds more strongly to heparin (a highly sulfated form of HS) than CCP19–20, and that their sulfate specificities are different. Furthermore, the HS binding site in CCP6–8, which is affected by the AMD-associated Y402H polymorphism, plays the principal role in host tissue recognition in the human eye, whereas the CCP19–20 region makes the major contribution to the binding of CFH in the human kidney. This helps provide a biochemical explanation for the genetic basis of tissue-specific diseases such as AMD and atypical hemolytic uremic syndrome, and leads to a better understanding of the pathogenic mechanisms for these diseases of complement dysregulation.

1 November 2012 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
TKTiarnan D. L. Keenan
Tiarnan D. L. Keenan
SCSimon John Clark
Simon John Clark
RURichard Unwin
Richard Unwin
LRLiam A. Ridge
Liam A. Ridge
ADAnthony Day
Anthony Day
PBPaul Bishop
Paul Bishop
To examine the presence and distribution of proteoglycan (PG) core proteins in the adult human retina, choroid, and sclera. Postmortem human eye tissue was dissected into Bruch's membrane/choroid complex, isolated Bruch's membrane, or neurosensory retina. PGs were extracted and partially purified by anion exchange chromatography. Trypsinized peptides were analyzed by tandem mass spectrometry and PG core proteins identified by database search. The distribution of PGs was examined by immunofluorescence microscopy on human macular tissue sections. The basement membrane PGs perlecan, agrin, and collagen-XVIII were identified in the human retina, and were present in the internal limiting membrane, blood vessel walls, and Bruch's membrane. The hyalectans versican and aggrecan were also detected. Versican was identified in Bruch's membrane, while aggrecan was distributed throughout the retina, choroid, and sclera. The cartilage link protein HAPLN1 was abundant in the interphotoreceptor matrix and sclera, while HAPLN4 (brain link protein 2) was found throughout the retina and choroid. The small leucine-rich repeat PG (SLRP) family members biglycan, decorin, fibromodulin, lumican, mimecan, opticin, and prolargin were present, with different patterns of distribution in the retina, choroid, and sclera. A combination of proteomics and immunohistochemistry approaches has provided for the first time a comprehensive analysis of the presence and distribution of PG core proteins throughout the human retina, choroid, and sclera. This complements our knowledge of glycosaminoglycan chain distribution in the human eye, and has important implications for understanding the structure and functional regulation of the eye in health and disease.

30 October 2017 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
LRLiam A. Ridge
Liam A. Ridge
KMKaren Mitchell
Karen Mitchell
AAAli Al-Anbaki
Ali Al-Anbaki
WQWasay Mohiuddin Shaikh Qureshi
Wasay Mohiuddin Shaikh Qureshi
LSLouise A. Stephen
Louise A. Stephen
KHKathryn Hentges
Kathryn Hentges
The coronary vasculature is an essential vessel network providing the blood supply to the heart. Disruptions in coronary blood flow contribute to cardiac disease, a major cause of premature death worldwide. The generation of treatments for cardiovascular disease will be aided by a deeper understanding of the developmental processes that underpin coronary vessel formation. From an ENU mutagenesis screen, we have isolated a mouse mutant displaying embryonic hydrocephalus and cardiac defects (EHC). Positional cloning and candidate gene analysis revealed that the EHC phenotype results from a point mutation in a splice donor site of the Myh10 gene, which encodes NMHC IIB. Complementation testing confirmed that the Myh10 mutation causes the EHC phenotype. Characterisation of the EHC cardiac defects revealed abnormalities in myocardial development, consistent with observations from previously generated NMHC IIB null mouse lines. Analysis of the EHC mutant hearts also identified defects in the formation of the coronary vasculature. We attribute the coronary vessel abnormalities to defective epicardial cell function, as the EHC epicardium displays an abnormal cell morphology, reduced capacity to undergo epithelial-mesenchymal transition (EMT), and impaired migration of epicardial-derived cells (EPDCs) into the myocardium. Our studies on the EHC mutant demonstrate a requirement for NMHC IIB in epicardial function and coronary vessel formation, highlighting the importance of this protein in cardiac development and ultimately, embryonic survival. In order for the heart to function properly it must have its own blood supply. Blood is delivered to the heart through a system of vessels called the coronary vasculature. During development, some of the cells that form the coronary vessels originate from the epicardium, the outer layer of the heart. These epicardial-derived cells migrate into the cardiac tissue where they contribute to the formation of the coronary vascular network. We have found that a mouse mutant containing a mutation in the gene Myh10, which encodes the cytoskeletal protein non-muscle myosin IIB, fails to form the coronary vasculature. Our work reveals defects in the epicardium, which contribute to the lack of coronary vessel development in this mutant. Surprisingly, we discovered that whilst the mutant epicardial cells are capable of movement when extracted from the embryo, these cells fail to mobilise into a vascular network in the context of the developing embryonic heart. We propose that this migration failure is due to abnormalities in the extracellular environment in the mutant heart. This work highlights the importance of the Myh10 gene in the critical developmental process of coronary vessel formation.

24 June 2014 in Genesis
Verified
Journal Article
Open access
PDF file
CCChristopher Clowes
Christopher Clowes
MBMichael G.S. Boylan
Michael G.S. Boylan
LRLiam A. Ridge
Liam A. Ridge
EBEmma Barnes
Emma Barnes
JWJayne A. Wright
Jayne A. Wright
KHKathryn Hentges
Kathryn Hentges
Summary: Genes required for an organism to develop to maturity (for which no other gene can compensate) are considered essential. The continuing functional annotation of the mouse genome has enabled the identification of many essential genes required for specific developmental processes including cardiac development. Patterns are now emerging regarding the functional nature of genes required at specific points throughout gestation. Essential genes required for development beyond cardiac progenitor cell migration and induction include a small and functionally homogenous group encoding transcription factors, ligands and receptors. Actions of core cardiogenic transcription factors from the Gata, Nkx, Mef, Hand, and Tbx families trigger a marked expansion in the functional diversity of essential genes from midgestation onwards. As the embryo grows in size and complexity, genes required to maintain a functional heartbeat and to provide muscular strength and regulate blood flow are well represented. These essential genes regulate further specialization and polarization of cell types along with proliferative, migratory, adhesive, contractile, and structural processes. The identification of patterns regarding the functional nature of essential genes across numerous developmental systems may aid prediction of further essential genes and those important to development and/or progression of disease. genesis 52:713–737, 2014. © 2014 The Authors. Genesis Published by Wiley Periodicals, Inc.

29 September 2015 in Toxicology Letters
Verified
Journal Article
Closed access
LRL. Ridge
L. Ridge
GTG. Tenin
G. Tenin
KHK. Hentges
K. Hentges
EBE. Barnes
E. Barnes
JWJ. Wright
J. Wright

31 August 2011 in Molecular Immunology
Verified
Journal Article
Closed access
JCJ. Clark
J. Clark
LRL.A. Ridge
L.A. Ridge
AHA.P. Herbert
A.P. Herbert
SHS. Hakobyan
S. Hakobyan
BMB. Mulloy
B. Mulloy
ADAnthony Day
Anthony Day